ARCHIVES

Study Disproves “Old Saw,” Finds Life No Worse for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 08 No. 47 | December 3, 1982

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Other DCT Concepts Approved By BSC

June 6, 1986

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007